[ET Net News Agency, 1 March 2024] LAEKNA-B (02105) rose 21.5% to HK$7.
It hits an intra-day high of HK$7, hitting an 1-month high, and an intra-day low of
HK$5.55. The total shares traded was 11.65 million, with a value of HK$72.09m. The active
buy/sell ratio is 55:45, with net buying turnover of HK$6.89m. GOLDMAN SACHS (ASIA) SEC
accounts for greatest net responsive buying turnover of HK$3.18m, with volume weighted
average price of HK$6.158. CHINA INNOVATION MARKET SER accounts for greatest net
responsive selling turnover of HK$3.1m, with volume weighted average price of HK$6.213.
The stock has risen a combined 93.4% over the past 3 consecutive trading days.
Basic Information
=================
----------------------------------
Nominal 7.000 % Chg +21.53%
High 7.000 Low 5.550
Shares Tr 11.65m Turnover 72.09m
10-D SMA 4.178 %H.V 202.740
20-D SMA 3.992 VWAP 6.188
50-D SMA 9.745 RSI14 57.664
----------------------------------
Status: Hitting an 1-month high, active buy/sell ratio is 55:45, with net buying turnover
of HK$6.89m, rising a combined 93.4% over the past 3 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
LAEKNA-B (02105) 7.00 +21.53
HUTCHMED (00013) 24.40 +0.83
GENSCRIPT BIO (01548) 15.34 -3.03
INNOVENT BIO (01801) 40.40 -4.60
EVEREST MED-B (01952) 24.80 +2.69
SIRNAOMICS-B (02257) 14.32 +12.23
WUXI BIO (02269) 19.02 -0.10
BEIGENE (06160) 99.30 -6.32
AKESO (09926) 47.60 +1.06
REMEGEN (09995) 22.45 -0.22
---------------------------------------------
(ed)